Praxis Precision Medicines, Inc. PRAX Elsunersen — Program-specific expenses

Other product segments

Similar metrics at other companies

HGVMarketing expense — Expenses

$239M+3.9%

HGVRental expense — Expenses

$204M+4.6%

HGVSelling expense — Expenses

$181M-7.2%

HGVClub expense — Expenses

$22M+10.0%

HGVLicense fee expense — Expenses

$53M+8.2%

HGVProperty management expense — Expenses

$37M+8.8%

FAQ

What is Praxis Precision Medicines, Inc.'s elsunersen — program-specific expenses?

Praxis Precision Medicines, Inc. (PRAX) reported elsunersen — program-specific expenses of $8.14M in Q2 2026.

How has Praxis Precision Medicines, Inc.'s elsunersen — program-specific expenses changed year-over-year?

Praxis Precision Medicines, Inc.'s elsunersen — program-specific expenses increased by 518.1% year-over-year, from $1.32M to $8.14M.

What is the long-term trend for Praxis Precision Medicines, Inc.'s elsunersen — program-specific expenses?

Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s elsunersen — program-specific expenses has grown at a -31.6% compound annual growth rate (CAGR), from $14.6M to $6.83M.

What does elsunersen — program-specific expenses mean?

This metric represents the direct costs associated with the research, development, and production activities specifically allocated to the Elsunersen therapeutic program. It captures the financial resources deployed to advance this clinical candidate through its development lifecycle, including manufacturing and service-related expenditures. Monitoring these costs provides insight into the capital intensity and operational efficiency of the firm's specific drug development pipeline.